Márquez HJC, Rojas BL, Ávila AN, Pacheco GC, Calderón FF

Language: Spanish
References: 8
Page: 307-311
PDF size: 71.65 Kb.

ABSTRACT

Introduction. The economic cost of prostate cancer and in continuous grow. The number of cases is increasing since the discovery of the prostate specific antigen. In Mexico we do not have any economic study of the disease cost. Nevertheless it is considered a 5 to 6% of the oncologic health budget. Materials and methods. We used a study that is descriptive, observational, retrolective and longitudinal. Results. We obtained a total cost for a year of treatment of $1.929,004.00, with a range per patient of $17,629.00 ($4,462.00 - $40,621.00) with a standard deviation of 9929.00. With a hospital expenses of $24,146.00 ($3,405.00 - $59,000.00) representing a total expenses of 0.01% of the hospital total budget. Conclusions. This represents an expense of 111% of the minimum national wage for the detection and control of prostate cancer, therefore the economic cost of prostate cancer is steadily rising in our country. This disease is an economic burden, and incredibly there is no study plans, no economic planning for this disease in our country.

REFERENCES

1. Grover SA, Zowall H, Coupal L. Prostate Cancer: The economic Burden. CMAJ 1999; 160(5).

2. Otnes B, Harvey S, Fossa SD. The burden of prostate cancer from diagnosis until death. Br J Urol 1995; 76: 587-94.

3. Reportes del INEGI, www.ssa.gob.mx

4. Moore R, Mao Y, Zang J, Clarke K. Economic burden of illness in Canada, 1993. Ottawa: Health Canada; 1997.

5. Hodgson TA. The state of the art of cost-of-illness estimates. Adv Health Econ Health Serv Res 1983; 4: 129-64.

6. Obrien B, Viramontes JL. Willingness to pay: A valued and reliable measure of health state preference. Med Decis Making 1994; 14: 289-97.

7. Resource intensity weights: Summary of methodology, 1996-97. Ottawa: Canadian Institute for Health Information; 1996.

8. Anderson GM. An overview of the use of acute care hospitals, physicians and diagnostic services and prescription drugs. In: Naylor CD, Anderson GM, Goel UV editors. Patterns of health care in Ontario: The ICES practice Atlas. 1ed. Ottawa: Canadian Medical Association; 1994, p. 214.